Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.760
-0.010 (-0.56%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $670.51 million as of April 17, 2025. Its market cap has decreased by -38.94% in one year.
Market Cap
670.51M
Enterprise Value
-170.03M
1-Year Change
-38.94%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $670.51M, a decrease of -41.09%. That is a compound annual growth rate of -7.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 677.10M | -12.32% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |